These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8855846

  • 21. [Venous pathology with estrogens-progestagens].
    Vin F, Allaert FA, Levardon M.
    Phlebologie; 1989; 42(3):473-9; discussion 479-80. PubMed ID: 2626469
    [No Abstract] [Full Text] [Related]

  • 22. Patch instead of pill: a safer menopausal estrogen?
    Cushman M.
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):136-7. PubMed ID: 20089948
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Clinical significance of the androgenicity of progestins in hormonal therapy in women.
    Linn ES.
    Clin Ther; 1990 Feb; 12(5):447-55. PubMed ID: 2268868
    [Abstract] [Full Text] [Related]

  • 25. [Hormone replacement therapy in menopause, hemostasis and thromboembolic risk].
    Levesque H, Cailleux N, Courtois H.
    J Mal Vasc; 1994 Feb; 19(2):93-7. PubMed ID: 8077869
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clinical evaluation of side effects of current oral contraceptives.
    Nelson JH.
    J Reprod Med; 1971 Feb; 6(2):50-5. PubMed ID: 4255975
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE.
    Acta Endocrinol (Copenh); 1991 Feb; 125 Suppl 1():13-26. PubMed ID: 1801500
    [Abstract] [Full Text] [Related]

  • 31. Effects of hormone treatment on hemostasis variables.
    Kluft C.
    Climacteric; 2007 Oct; 10 Suppl 2():32-7. PubMed ID: 17882670
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hormone replacement therapy: estrogen after menopause.
    Gibaldi M.
    Pharmacotherapy; 1996 Oct; 16(3):366-75. PubMed ID: 8726594
    [No Abstract] [Full Text] [Related]

  • 34. Hormone replacement therapy and ovarian cancer risk--any news?
    Riman T.
    Acta Obstet Gynecol Scand; 2007 Oct; 86(9):1032-4. PubMed ID: 17712640
    [No Abstract] [Full Text] [Related]

  • 35. [Vascular disorders and synthetic estroprogestatives].
    Servelle M, Babilliot J.
    Phlebologie; 1972 Oct; 25(3):259-61. PubMed ID: 4662051
    [Abstract] [Full Text] [Related]

  • 36. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
    Canonico M, Fournier A, Carcaillon L, Olié V, Plu-Bureau G, Oger E, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F, Scarabin PY.
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
    [Abstract] [Full Text] [Related]

  • 37. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H, de Moerloose P, Campana A.
    Schweiz Med Wochenschr; 1996 Oct 12; 126(41):1756-63. PubMed ID: 8966508
    [Abstract] [Full Text] [Related]

  • 38. [Risk of venous thrombosis during postmenopausal estrogen therapy? The reporting system of adverse effects is functioning].
    Buajordet I, Dybwad TB.
    Tidsskr Nor Laegeforen; 1997 Aug 10; 117(18):2644-5. PubMed ID: 9324824
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Exogenous sex hormones and thrombophilia.
    Walker ID.
    Obstet Gynecol Clin North Am; 2006 Sep 10; 33(3):467-79, x. PubMed ID: 16962922
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.